Processed Food Type 2 Diabetes Lawsuit Alleges Companies Targeted Children With Toxic, Addictive Ingredients
Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Proving Antibacterial Soap Effectiveness Goal of New FDA Rules December 17, 2013 Irvin Jackson Add Your Comments Federal health regulators are proposing new rules that will require manufacturers of antibacterial soap to establish that their products actually work as advertised. On Monday, the FDA announced a proposed rule that would require antibacterial hand soap and body wash manufacturers to show that their products are effective and that they have been scientifically tested. The new regulation came following strong protests by the industry. The FDA requirements would affect about 2,000 antibacterial soap products, which account for about half of the $900 million in liquid soap sold in 2012. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The proposed rule comes as the FDA faces a court-ordered deadline to regulate triclosan, the active ingredient in many antibacterial soaps, by 2016. The deadline was set following a lawsuit by the Natural Resources Defense Council, an environmental group. However, the rule will affect a number of chemicals; not just triclosan. In recent years, concerns have arisen about the use of triclosan, which some studies say could cause muscle damage. Triclosan is added to many personal care products as an antibacterial agent. It is used in hand soap, deodorants, toothpaste and is added to other products like bedding, clothing and toys to reduce the risk of bacterial contamination. The U.S. Environmental Protection Agency estimates that more than 1 million pounds of triclosan are produced annually in the U.S. According to the consumer watchdog group Beyond Pesticides, formerly known as the National Coalition Against the Misuse of Pesticides, numerous common products are known to contain triclosan including Dial Liquid Soap, Clearasil Daily Face Wash, Colgate Total Toothpaste, Revlon ColorStay LipSHINE Lip color, Old Spice High Endurance Stick Deodorant and many others. However, many companies are already phasing triclosan out of use, due to the concerns. Other Antibacterial Soap Concerns Regardless of concerns over triclosan, the FDA says there is little evidence that antibacterial soaps actually work any better than soap and water. Agency officials also say that in addition to triclosan’s health concerns, the widespread use of antibacterial soaps could cause other health risks, including bacterial resistance and hormonal effects. “Antibacterial soaps and body washes are used widely and frequently by consumers in everyday home, work, school, and public settings, where the risk of infection is relatively low,” Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research (CDER), said in the FDA press release. “Due to consumers’ extensive exposure to the ingredients in antibacterial soaps, we believe there should be a clearly demonstrated benefit from using antibacterial soap to balance any potential risk.” The antibacterial soap industry disagrees with the FDA position, maintaining that it has proven the effectiveness of its products repeatedly. “Over the past two decades, manufacturers of these products have provided significant data and information to the Agency about the safety and efficacy of this product category,” according to a statement released by the American Cleaning Institute and the Personal Care Products Council. “We are perplexed that the Agency would suggest that there is no evidence that antibacterial soaps are beneficial as industry has long provided data and information about the safety and efficacy of these products.” However, the groups also say that they applaud the FDA for the rulemaking overall, and believe the industry will be able to provide the agency with evidence proving the products’ effectiveness by submitting data already available. The proposed rule making has a public comment period of six months, which will be followed by a 60-day rebuttal period. The regulations will go into effect one year after a final rule is published. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Antibacterial Soap, Infection, Triclosan More Lawsuit Stories Depo-Provera Brain Tumor Risks Make Birth Control Shot Unreasonably Dangerous: Lawsuit February 20, 2026 Judge Clears DraftKings Lawsuit Over Deceptive Practices To Move Forward February 20, 2026 Processed Food Type 2 Diabetes Lawsuit Alleges Companies Targeted Children With Toxic, Addictive Ingredients February 20, 2026 0 Comments LinkedInThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Depo-Provera Brain Tumor Risks Make Birth Control Shot Unreasonably Dangerous: Lawsuit (Posted: yesterday) A New York woman has filed a lawsuit alleging that her long term use of Depo Provera caused her to develop a meningioma brain tumor, which she contends resulted from the manufacturer’s negligence and failure to adequately warn about the risks. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Indicates Depo-Provera Meningioma Lawsuits Should Be Preempted by Federal Law (02/03/2026)Proposed Depo-Provera Lawsuit Schedule Calls for First Trial in Dec. 2026 (01/23/2026)Lawsuit Indicates Depo-Provera Meningioma Diagnosis Followed Memory Loss, Dizziness Symptoms (01/20/2026) MDL Sought for Dupixent Lymphoma Lawsuits Filed in Federal Courts Nationwide (Posted: 2 days ago) A group of plaintiffs has petitioned the U.S. Judicial Panel on Multidistrict Litigation to centralize all Dupixent lymphoma lawsuits before a single judge for coordinated pretrial proceedings, a move that could ultimately lead to bellwether trials and a global resolution of the claims. MORE ABOUT: DUPIXENT LAWSUITLawsuit Claims Dupixent for Atopic Dermatitis, Eczema Treatment Caused CTCL (02/10/2026)CTCL Diagnosis Leads to Lawsuit Over Dupixent Cancer Risks (02/03/2026)Lawsuit Claims Dupixent Side Effects Led to CTCL Cancer Diagnosis (01/12/2026) $7.25B Roundup Class Settlement Proposed To Resolve Non-Hodgkin’s Lymphoma Lawsuits (Posted: 3 days ago) Bayer and Monsanto say they have reached a $7.25 billion Roundup cancer lawsuit settlement resolving more than 100,000 claims as well as any future litigation that may be filed. MORE ABOUT: ROUNDUP LAWSUITSRoundup Settlement Program Remains Option With Supreme Court Review Pending: MDL Judge (02/09/2026)Future of Roundup Lawsuits Over Non-Hodgkin’s Lymphoma To Be Decided by U.S. Supreme Court (01/19/2026)Roundup Safety Study Retracted Decades After Publication (12/08/2025)
Depo-Provera Brain Tumor Risks Make Birth Control Shot Unreasonably Dangerous: Lawsuit February 20, 2026
Processed Food Type 2 Diabetes Lawsuit Alleges Companies Targeted Children With Toxic, Addictive Ingredients February 20, 2026
Depo-Provera Brain Tumor Risks Make Birth Control Shot Unreasonably Dangerous: Lawsuit (Posted: yesterday) A New York woman has filed a lawsuit alleging that her long term use of Depo Provera caused her to develop a meningioma brain tumor, which she contends resulted from the manufacturer’s negligence and failure to adequately warn about the risks. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Indicates Depo-Provera Meningioma Lawsuits Should Be Preempted by Federal Law (02/03/2026)Proposed Depo-Provera Lawsuit Schedule Calls for First Trial in Dec. 2026 (01/23/2026)Lawsuit Indicates Depo-Provera Meningioma Diagnosis Followed Memory Loss, Dizziness Symptoms (01/20/2026)
MDL Sought for Dupixent Lymphoma Lawsuits Filed in Federal Courts Nationwide (Posted: 2 days ago) A group of plaintiffs has petitioned the U.S. Judicial Panel on Multidistrict Litigation to centralize all Dupixent lymphoma lawsuits before a single judge for coordinated pretrial proceedings, a move that could ultimately lead to bellwether trials and a global resolution of the claims. MORE ABOUT: DUPIXENT LAWSUITLawsuit Claims Dupixent for Atopic Dermatitis, Eczema Treatment Caused CTCL (02/10/2026)CTCL Diagnosis Leads to Lawsuit Over Dupixent Cancer Risks (02/03/2026)Lawsuit Claims Dupixent Side Effects Led to CTCL Cancer Diagnosis (01/12/2026)
$7.25B Roundup Class Settlement Proposed To Resolve Non-Hodgkin’s Lymphoma Lawsuits (Posted: 3 days ago) Bayer and Monsanto say they have reached a $7.25 billion Roundup cancer lawsuit settlement resolving more than 100,000 claims as well as any future litigation that may be filed. MORE ABOUT: ROUNDUP LAWSUITSRoundup Settlement Program Remains Option With Supreme Court Review Pending: MDL Judge (02/09/2026)Future of Roundup Lawsuits Over Non-Hodgkin’s Lymphoma To Be Decided by U.S. Supreme Court (01/19/2026)Roundup Safety Study Retracted Decades After Publication (12/08/2025)